|

VB15010 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Zhejiang Yangli Pharmaceutical Technology Co., Ltd.1

Indications

  • PARP1
  • Neoplasms, Breast1
  • Prostatic Cancer1
  • Tumor1
  • Ovarian Neoplasms1

Other1 trial

Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.